The 30th International Conference entitled "Advances in the Applications of Monoclonal Antibodies in Clinical Oncology and Symposium on Cancer Stem Cells" will be held from the 24th to the 26th June 2013 at the Santa Marina Hotel in Mykonos, Greece.
The 3rd International Conference with the title "Notch Targeting in Cancer" will take place from the 26th to the 28th June 2013 at the Santa Marina Hotel in Mykonos, Greece.
The previous Conferences 'Notch targeting in cancer' conference were accredited by the Accreditation Council of Oncology in Europe (ACOE) with 14 CME points and we expect the 3rd and all future conferences to be accredited. The program of the meeting has been recognized as having a high quality value both from a scientific and didactic point of view.
Cancer Conferences is an organisation dedicated to connecting the scientific community for the benefit of mankind.
We organize and conduct medical and scientific conferences on oncology topics, such as monoclonal antibodies and other key and novel areas such as therapeutic aspects of Notch in cancer, and their applications and impact in preclinical and clinical studies.
The Conferences originated at the Hammersmith Hospital, the Royal Postgraduate Medical School, London, in 1983. They are the first international conferences to be organized and held in the field.
More recently the Conferences have been held in the Greek Islands.
Anything that has proven to be worthwhile and anybody that has pioneered work in the Monoclonal Antibody area has first presented at these forums. Over the last 28 years, the Conferences have evolved and developed many of their popular features such as a strong interdisciplinary nature, an interactive style of presentations and unique open air workshops, discussions and debates.
In 2012 we will be having the 2nd International Conference "Notch Targeting in Cancer", which will be held back to back with the 29th International Conference "Advances in the Applications of Monoclonal Antibodies in Clinical Oncology and Symposium on Cancer Stem Cells".
